![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
RNS Number:5470M Celsis International PLC 22 November 2006 Celsis International plc ("the Company") Holding in Company Celsis International plc announces that it received notification on 22 November 2006 that, as at 17 November 2006, Barclays PLC had a notifiable interest in 1,601,936 ordinary shares in the Company. The registered Holders are detailed below: Registered Holder Holding % Barclays Global Investors Ltd 1,417,917 6.307% Barclays Life Assurance Co Ltd 183,089 0.814% Gerrard Ltd 930 0.004% Group Holding 1,601,936 7.125% The notifiable interest represents approximately 7.125 per cent. of the issued share capital of the Company. This information is provided by RNS The company news service from the London Stock Exchange END HOLUUUNRNURAUAA
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions